Book contents
- Frontmatter
- Contents
- Preface
- Acknowledgements
- Section 1 Diaphragm and adjacent structures
- Section 2 Liver
- Case 11 Pseudocirrhosis of treated breast cancer metastases
- Case 12 Pseudocirrhosis of fulminant hepatic failure
- Case 13 Nutmeg liver
- Case 14 Nodular regenerative hyperplasia
- Case 15 Pseudoprogression of treated hepatic metastases
- Case 16 Pseudothrombosis of the portal vein
- Case 17 Biliary hamartomas
- Case 18 Nodular focal fatty infiltration of the liver
- Case 19 Nodular focal fatty sparing of the liver
- Case 20 Hepatocellular carcinoma mimicking focal nodular hyperplasia
- Case 21 Paradoxical signal gain in the liver
- Section 3 Biliary system
- Section 4 Spleen
- Section 5 Pancreas
- Section 6 Adrenal glands
- Section 7 Kidneys
- Section 8 Retroperitoneum
- Section 9 Gastrointestinal tract
- Section 10 Peritoneal cavity
- Section 11 Ovaries
- Section 12 Uterus and vagina
- Section 13 Bladder
- Section 14 Pelvic soft tissues
- Section 15 Groin
- Section 16 Bone
- Index
- References
Case 21 - Paradoxical signal gain in the liver
from Section 2 - Liver
Published online by Cambridge University Press: 05 November 2011
- Frontmatter
- Contents
- Preface
- Acknowledgements
- Section 1 Diaphragm and adjacent structures
- Section 2 Liver
- Case 11 Pseudocirrhosis of treated breast cancer metastases
- Case 12 Pseudocirrhosis of fulminant hepatic failure
- Case 13 Nutmeg liver
- Case 14 Nodular regenerative hyperplasia
- Case 15 Pseudoprogression of treated hepatic metastases
- Case 16 Pseudothrombosis of the portal vein
- Case 17 Biliary hamartomas
- Case 18 Nodular focal fatty infiltration of the liver
- Case 19 Nodular focal fatty sparing of the liver
- Case 20 Hepatocellular carcinoma mimicking focal nodular hyperplasia
- Case 21 Paradoxical signal gain in the liver
- Section 3 Biliary system
- Section 4 Spleen
- Section 5 Pancreas
- Section 6 Adrenal glands
- Section 7 Kidneys
- Section 8 Retroperitoneum
- Section 9 Gastrointestinal tract
- Section 10 Peritoneal cavity
- Section 11 Ovaries
- Section 12 Uterus and vagina
- Section 13 Bladder
- Section 14 Pelvic soft tissues
- Section 15 Groin
- Section 16 Bone
- Index
- References
Summary
Imaging description
In and out of phase T1-weighted gradient-echo MRI of the liver is mainly used to evaluate diffuse fatty infiltration. Normal liver has the same signal intensity on in and out of phase images (Figure 21.1). Fatty liver shows a loss of signal on out of phase versus in phase images (Figure 21.2), due to chemical-shift-related signal cancellation between fat and water protons. Occasionally, the liver is brighter on out of phase versus in phase images (Figure 21.3). This is known as paradoxical signal gain and is due to hepatic iron overload causing T2* related signal loss on in phase imaging [1], since in phase images are typically acquired with a longer echo time (in a 1.5T scanner, out of phase images are usually acquired at a TE of 2.1 milliseconds with in phase images acquired at a TE of 4.2 milliseconds). With a longer echo time, iron-induced signal loss becomes more pronounced (such T2* effects are negligible in livers unaffected by iron overload).
Importance
Paradoxical signal gain on out of phase MRI can be seen with liver iron concentrations of 80 μ iron per gram and above [2]. This threshold is about twice the upper limit of normal liver iron concentration (36 μmol per gram) and is considered clinically significant [3], so that the detection of this phenomenon merits recognition and reporting. Liver iron overload also confounds the detection of diffuse fatty infiltration on out of phase MRI [4], because iron and fat have the opposite effect on signal dropout.
- Type
- Chapter
- Information
- Pearls and Pitfalls in Abdominal ImagingPseudotumors, Variants and Other Difficult Diagnoses, pp. 68 - 71Publisher: Cambridge University PressPrint publication year: 2010